Milk protein peptide (null)

Milk protein peptides are short chains of amino acids (typically 2–20 residues) released from milk proteins (such as casein and whey) through proteolytic digestion or fermentation. These peptides are latent within the parent proteins and become bioactive upon enzymatic release. Milk protein peptides include a diverse range of molecules, each with specific amino acid sequences, and collectively they exert multiple biological effects—including inhibition of angiotensin-converting enzyme (ACE, blood pressure regulation), DPP-IV inhibition (relevant for glucose metabolism), antimicrobial activity, immune modulation, antioxidative stress reduction, opioid receptor interactions, and enhancement of mineral absorption. Most of these peptides are not direct drug targets but are studied for nutritional and functional food applications as well as potential therapeutic effects. The field covers a very wide array of sequences and putative biological functions, but "milk protein peptides" is not a single discrete molecular entity, gene, or receptor. Because "milk protein peptides" names a family rather than a specific molecular target, it is formally inaccurate to treat this as you would a distinct drug target such as "Angiotensin-converting enzyme." Instead, for structured annotation or database work, it is best treated as a peptide class or source of bioactive components, not as a canonical drug target.

Other names

Bioactive milk peptidedairy-derived peptidecasein peptidewhey protein peptide

Enzyme inhibition (e.g., ACE, DPP-IV); Binding to opioid receptors (some peptides); Modulation of immune cell function; Mineral chelation/absorption enhancement; Antimicrobial membrane interactions